ATE240121T1 - Verfahren zur herstellung von absorbierbaren mikropartikeln - Google Patents
Verfahren zur herstellung von absorbierbaren mikropartikelnInfo
- Publication number
- ATE240121T1 ATE240121T1 AT99902793T AT99902793T ATE240121T1 AT E240121 T1 ATE240121 T1 AT E240121T1 AT 99902793 T AT99902793 T AT 99902793T AT 99902793 T AT99902793 T AT 99902793T AT E240121 T1 ATE240121 T1 AT E240121T1
- Authority
- AT
- Austria
- Prior art keywords
- microparticles
- producing
- producing absorbable
- absorbable microparticles
- absorbable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6927—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IE980054 | 1998-01-29 | ||
| PCT/IE1999/000007 WO1999038535A1 (en) | 1998-01-29 | 1999-01-25 | Process for making absorbable microparticles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE240121T1 true ATE240121T1 (de) | 2003-05-15 |
Family
ID=11041696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99902793T ATE240121T1 (de) | 1998-01-29 | 1999-01-25 | Verfahren zur herstellung von absorbierbaren mikropartikeln |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6555156B1 (de) |
| EP (1) | EP1051194B9 (de) |
| JP (1) | JP2002501907A (de) |
| CN (1) | CN1289255A (de) |
| AR (1) | AR014069A1 (de) |
| AT (1) | ATE240121T1 (de) |
| AU (1) | AU740493B2 (de) |
| CA (1) | CA2318513A1 (de) |
| DE (1) | DE69907870T2 (de) |
| DK (1) | DK1051194T3 (de) |
| ES (1) | ES2194437T3 (de) |
| HU (1) | HUP0102373A2 (de) |
| IL (1) | IL137349A0 (de) |
| NO (1) | NO20003804L (de) |
| PL (1) | PL342135A1 (de) |
| PT (1) | PT1051194E (de) |
| WO (1) | WO1999038535A1 (de) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6413539B1 (en) * | 1996-10-31 | 2002-07-02 | Poly-Med, Inc. | Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof |
| US6861053B1 (en) | 1999-08-11 | 2005-03-01 | Cedars-Sinai Medical Center | Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth |
| US7048906B2 (en) | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| IES990700A2 (en) * | 1999-08-18 | 2001-08-22 | Kinerton Ltd | Process to make a sustained release formulation |
| US6756480B2 (en) | 2000-04-27 | 2004-06-29 | Amgen Inc. | Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
| US7229966B2 (en) | 2002-12-17 | 2007-06-12 | Nastech Pharmaceutical Company Inc. | Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity |
| US7186692B2 (en) | 2002-12-17 | 2007-03-06 | Nastech Pharmaceutical Company Inc. | Compositions and methods for enhanced mucosal delivery and non-infused administration of Y2 receptor-binding peptides and methods for treating and preventing obesity |
| US7166575B2 (en) | 2002-12-17 | 2007-01-23 | Nastech Pharmaceutical Company Inc. | Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity |
| BR0316685A (pt) | 2002-12-17 | 2005-11-01 | Nastech Pharm Co | Composições e métodos para a administração aperfeiçoada por via mucosal de peptìdeos fixadores ao receptor de y2 e métodos para tratar e prevenir a obesidade |
| KR20070010115A (ko) * | 2003-11-13 | 2007-01-22 | 알자 코포레이션 | 경피전달용 조성물 및 장치 |
| US7976847B2 (en) * | 2004-01-13 | 2011-07-12 | Vasogenix Pharmaceuticals, Inc. | Controlled release CGRP delivery composition for cardiovascular and renal indications |
| JP2007517911A (ja) * | 2004-01-13 | 2007-07-05 | バソジェニックス ファーマシューティカルズ， インコーポレイテッド | 心臓血管の適応症および腎臓の適応症に対してｃｇｒｐを使用する方法 |
| EP1703916A2 (de) * | 2004-01-13 | 2006-09-27 | Vasogenix Pharmaceuticals, Inc. | Verfahren zur behandlung eines akuten myokardinfarkts mit einem mit dem calicitonin-gen in verbindung stehenden peptid sowie dieses enthaltende zusammensetzungen |
| US7578951B2 (en) * | 2004-01-27 | 2009-08-25 | Hewlett-Packard Development Company, L.P. | Method of making microcapsules utilizing a fluid ejector |
| CA2584670A1 (en) | 2004-10-19 | 2006-04-27 | Achillion Pharmaceuticals, Inc. | Combination therapy for treating viral infections |
| FR2880272A1 (fr) * | 2005-01-04 | 2006-07-07 | Jean Marc Ruiz | Preparation contenant des microparticules d'un sel de polymere insoluble portant un principe actif, ainsi que son procede de fabrication |
| DK2118123T3 (en) | 2007-01-31 | 2016-01-25 | Dana Farber Cancer Inst Inc | Stabilized p53 peptides and uses thereof |
| US8592377B2 (en) | 2007-03-28 | 2013-11-26 | President And Fellows Of Harvard College | Stitched polypeptides |
| CA2730760A1 (en) * | 2008-07-16 | 2010-01-21 | Surmodics Pharmaceuticals, Inc. | Process for preparing microparticles containing bioactive peptides |
| US8968787B2 (en) * | 2010-05-24 | 2015-03-03 | Micro Powders, Inc. | Composition comprising biodegradable polymers for use in a cosmetic composition |
| ES2711526T3 (es) | 2010-08-13 | 2019-05-06 | Aileron Therapeutics Inc | Macrociclos peptidomiméticos |
| DE102011114864A1 (de) | 2011-10-05 | 2013-04-11 | Acino Ag | Verfahren zur Herstellung einer homogenen Pulvermischung und Verfahren zur Herstellung eines Implantats sowie Implantat |
| TW201806968A (zh) | 2011-10-18 | 2018-03-01 | 艾利倫治療公司 | 擬肽巨環化合物 |
| EP2819688A4 (de) | 2012-02-15 | 2015-10-28 | Aileron Therapeutics Inc | Triazol- und thioethervernetzte peptidomimetische makrozyklen |
| BR112014020103A2 (pt) | 2012-02-15 | 2018-10-09 | Aileron Therapeutics, Inc. | macrociclos peptidomiméticos |
| WO2014071241A1 (en) | 2012-11-01 | 2014-05-08 | Aileron Therapeutics, Inc. | Disubstituted amino acids and methods of preparation and use thereof |
| EP3197478A4 (de) | 2014-09-24 | 2018-05-30 | Aileron Therapeutics, Inc. | Peptidomimetische makrozyklen und verwendungen davon |
| WO2016154058A1 (en) | 2015-03-20 | 2016-09-29 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
| CA3004363A1 (en) | 2015-11-06 | 2017-05-11 | Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. | Composition comprising a biocompatible and biodegradable polymer, nanocarries and a drug and methods of making and using the same |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE52535B1 (en) | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
| US5385738A (en) | 1983-10-14 | 1995-01-31 | Sumitomo Pharmaceuticals Company, Ltd. | Sustained-release injection |
| US5011692A (en) | 1985-12-28 | 1991-04-30 | Sumitomo Pharmaceuticals Company, Limited | Sustained pulsewise release pharmaceutical preparation |
| US4938763B1 (en) | 1988-10-03 | 1995-07-04 | Atrix Lab Inc | Biodegradable in-situ forming implants and method of producing the same |
| US5077049A (en) | 1989-07-24 | 1991-12-31 | Vipont Pharmaceutical, Inc. | Biodegradable system for regenerating the periodontium |
| CA2046830C (en) | 1990-07-19 | 1999-12-14 | Patrick P. Deluca | Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer |
| AU653771B2 (en) * | 1991-01-03 | 1994-10-13 | Alkermes Controlled Therapeutics, Inc. | Stabilization of proteins by cationic biopolymers |
| US5366756A (en) | 1992-06-15 | 1994-11-22 | United States Surgical Corporation | Method for treating bioabsorbable implant material |
| US5672659A (en) | 1993-01-06 | 1997-09-30 | Kinerton Limited | Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| CA2167920A1 (en) * | 1993-07-23 | 1995-02-02 | Abraham J. Domb | Nonoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers |
| US5612052A (en) | 1995-04-13 | 1997-03-18 | Poly-Med, Inc. | Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof |
| US5665702A (en) | 1995-06-06 | 1997-09-09 | Biomeasure Incorporated | Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides |
| US5874029A (en) * | 1996-10-09 | 1999-02-23 | The University Of Kansas | Methods for particle micronization and nanonization by recrystallization from organic solutions sprayed into a compressed antisolvent |
| US6270700B1 (en) * | 1998-07-23 | 2001-08-07 | Societe De Conseils De Recherches Et D'applications Scientifiques, Sas | Encapsulation of water soluble peptides |
-
1999
- 1999-01-25 DE DE69907870T patent/DE69907870T2/de not_active Expired - Lifetime
- 1999-01-25 US US09/601,074 patent/US6555156B1/en not_active Expired - Fee Related
- 1999-01-25 IL IL13734999A patent/IL137349A0/xx unknown
- 1999-01-25 CA CA002318513A patent/CA2318513A1/en not_active Abandoned
- 1999-01-25 PL PL99342135A patent/PL342135A1/xx unknown
- 1999-01-25 HU HU0102373A patent/HUP0102373A2/hu unknown
- 1999-01-25 AT AT99902793T patent/ATE240121T1/de not_active IP Right Cessation
- 1999-01-25 DK DK99902793T patent/DK1051194T3/da active
- 1999-01-25 AR ARP990100287A patent/AR014069A1/es unknown
- 1999-01-25 AU AU22966/99A patent/AU740493B2/en not_active Ceased
- 1999-01-25 CN CN99802448A patent/CN1289255A/zh active Pending
- 1999-01-25 WO PCT/IE1999/000007 patent/WO1999038535A1/en not_active Ceased
- 1999-01-25 EP EP99902793A patent/EP1051194B9/de not_active Expired - Lifetime
- 1999-01-25 PT PT99902793T patent/PT1051194E/pt unknown
- 1999-01-25 JP JP2000529267A patent/JP2002501907A/ja active Pending
- 1999-01-25 ES ES99902793T patent/ES2194437T3/es not_active Expired - Lifetime
-
2000
- 2000-07-25 NO NO20003804A patent/NO20003804L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20003804D0 (no) | 2000-07-25 |
| WO1999038535A1 (en) | 1999-08-05 |
| US6555156B1 (en) | 2003-04-29 |
| CA2318513A1 (en) | 1999-08-05 |
| IL137349A0 (en) | 2001-07-24 |
| DK1051194T3 (da) | 2003-09-01 |
| PL342135A1 (en) | 2001-05-21 |
| HUP0102373A2 (hu) | 2001-10-28 |
| AU2296699A (en) | 1999-08-16 |
| AU740493B2 (en) | 2001-11-08 |
| AR014069A1 (es) | 2001-01-31 |
| EP1051194B9 (de) | 2003-11-05 |
| DE69907870D1 (de) | 2003-06-18 |
| DE69907870T2 (de) | 2004-03-04 |
| PT1051194E (pt) | 2003-09-30 |
| ES2194437T3 (es) | 2003-11-16 |
| JP2002501907A (ja) | 2002-01-22 |
| CN1289255A (zh) | 2001-03-28 |
| NO20003804L (no) | 2000-09-20 |
| EP1051194A1 (de) | 2000-11-15 |
| EP1051194B1 (de) | 2003-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE240121T1 (de) | Verfahren zur herstellung von absorbierbaren mikropartikeln | |
| ATE297892T1 (de) | Verfahren zur herstellung von azetidinonen | |
| DE69911398D1 (de) | Verfahren zur herstellung von 4-aminodiphenylaminen | |
| DE69913666D1 (de) | Verfahren zur herstellung von di-methyl-naphthalinen | |
| DE60005779D1 (de) | Verfahren zur herstellung von polyarylaten | |
| ATE339433T1 (de) | Verbessertes verfahren zur herstellung von makroliden | |
| DE60003264D1 (de) | Verfahren zur herstellung von glycerylethern | |
| DE69914469D1 (de) | Verfahren zur herstellung von hinokitiol | |
| DE50004356D1 (de) | Verfahren zur herstellung von adrenalin | |
| DE69907148D1 (de) | Verfahren zur herstellung von styrolen | |
| DE69910995D1 (de) | Verfahren zur herstellung von fluorkohlenwasserstoffen | |
| DE59901552D1 (de) | Verfahren zur herstellung von polyalkylenarylaten | |
| DE50006772D1 (de) | Verfahren zur herstellung von oxindolen | |
| DE69825880D1 (de) | Verfahren zur herstellung von eprosartan | |
| ATE424466T1 (de) | Verfahren zur herstellung von cyclodextrin | |
| EP1208106A4 (de) | Verfahren zur herstellung von aminopropyl- oder aminoalkyl-unktionalisierten polyalkyl- oder aryl-siloxanen | |
| DE69827240D1 (de) | Verfahren zur herstellung von eprosartan | |
| DE50001895D1 (de) | Verfahren zur herstellung von phosphonomethylglycin | |
| DE69901192D1 (de) | Verfahren zur herstellung von cyclopropanmethylamin | |
| ATE233238T1 (de) | Verfahren zur herstellung von 3-acyl-indolen | |
| ATE220697T1 (de) | Verfahren zur herstellung von polyester | |
| ATE272611T1 (de) | Verfahren zur herstellung von ketiminen | |
| DE69928784D1 (de) | Verfahren zur herstellung von oxazolidin-2-on-derivaten | |
| DE69910353D1 (de) | Verfahren zur herstellung von epsilon-caprolactam | |
| DE59903764D1 (de) | Verfahren zur herstellung von phytosqualan |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1051194 Country of ref document: EP |
|
| EEFA | Change of the company name | ||
| REN | Ceased due to non-payment of the annual fee |